ALPHARETTA, Ga., July 6, 2015 /PRNewswire/ -- EndoChoice Holdings, Inc. (NYSE: GI) announced today that it will release its second quarter 2015 financial results on Thursday, August 6, 2015 before the market open.
EndoChoice will hold a conference call on Thursday, August 6, 2015 at 9:00 a.m. ET to discuss the results. The dial-in numbers are (866) 807-9684 for domestic callers and (412) 317-5415 for international callers. A live webcast of the conference call will be available on the investor relations section of the Company's website at http://investor.endochoice.com.
A replay of the call will be available starting on August 6, 2015 through August 14, 2015. To access the replay, dial (877) 344-7529 for domestic and (412) 317-0088 for international callers, with the replay access code 10067875. The webcast replay will be available in the investor relations section of the Company's website for 90 days following the completion of the call.
Based near Atlanta, EndoChoice (NYSE: GI) is a medtech company focused on the manufacturing and commercialization of platform technologies including endoscopic imaging systems, devices and infection control products and pathology services for specialists diagnosing and treating a wide range of gastrointestinal conditions, including colon cancer. EndoChoice leverages its direct sales organization to serve more than 2,500 customers in the United States and works with distribution partners in 25 countries. The Company was founded in 2008 and has rapidly developed a broad and innovative product portfolio, which includes the Full Spectrum Endoscopy System (Fuse®). EndoChoice, Fuse, and Full Spectrum Endoscopy are registered trademarks of EndoChoice Holdings, Inc.
David Gill, Chief Financial Officer
SOURCE EndoChoice Holdings, Inc.